Image (Hyqvia 01)
Hyqvia Kit
Product Images NDC 0944-2513
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Hyqvia (NDC 0944-2513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Hyqvia 02)
Image (Hyqvia 03)
Image (Hyqvia 04)
Image (Hyqvia 05)
Image (Hyqvia 06)
Image (Hyqvia 07)
Figure 1 (Hyqvia 08)
This is a medical document referring to dosage adjustments for a study that was carried out for 28 days. The document shows dose adjustments of Hyquia and IGSC10% on study day 28. There is also a table with doses adjusted on different days, possibly showing the results of the study.*
Image (Hyqvia 09)
Image (Hyqvia 10)
Image (Hyqvia 11)
Image (Hyqvia 12)
Image (Hyqvia 13)
Image (Hyqvia 14)
Image (Hyqvia 15)
Image (Hyqvia 16)
Image (Hyqvia 17)
Image (Hyqvia 18)
Image (Hyqvia 19)
Image (Hyqvia 20)
Principal Display Panel (2.5 g/25 mL Vial Label)
This is a description of a medicine called "Immune Globulin Infusion 10% (Human)". It is a component of HYQVIA and comes in a single-use vial. It is a prescription-only medication and is manufactured by Baxalta US Inc. with a license number of 2020. There is also a code at the bottom of the text, but it is not clear what it signifies.*
Principal Display Panel (1.25 mL Vial Label)
This is a description of a medical product called "Recombinant Human Hyaluronidase" that is a component of a medicine called HYQVIA. It comes in a single-use vial with a volume of 125 mL. The manufacturer is Baxter Healthcare Corporation based in Deerfeld, IL, USA. There is also a lot and expiry date printed on the packaging, which reads "82r0v-20-31" and "5002, 29960500". This product is only available with a prescription.*
Principal Display Panel (2.5 g/25 mL Kit Carton)
This is a product description for a medication named HyQvia, which is a subcutaneous medication for immune globulin infusion in humans. It consists of two vials and contains recombinant human hyaluronidase. It is to be administered by a physician and requires a prescription. The medication should be kept at a certain temperature and has a shelf-life. The package insert should be read before use. The manufacturer is Baxter, and it is produced in the US.*
Principal Display Panel (5 g/50 mL Vial Label)
Principal Display Panel (2.5 mL Vial Label)
This is a description of a medical product called "Recombinant Human Hyaluronidase" manufactured by Baxter Healthcare Corporation. It is a component of a medication called HYQVIA, which most likely involves the use of human plasma. The product comes in single-use vials containing 25mL of solution, with a concentration of 160 units per mL. The text also provides the location of the company's headquarters in Deerfield, Illinois, USA.*
Principal Display Panel (5 g/50 mL Kit Carton)
HYQVIA is a product with carton contents of one 50ml dual vial unit, containing 5ml of Immune Globulin Infusion 10% (Human) and 160u Recombinant Human Hyaluronidase, to be subcutaneously administered. It is for single use only and there is no preservative. The refrigeration temperature is -2 to 5°C, however, it can also be stored at a temperature of 25°C for up to 3 months but should be used within the first 24 months from the date of manufacture. The product code is 1503388. It contains 85mg sodium chloride, 178mg dibasic sodium phosphate, 1g human albumin, 1mg edetate disodium, 0.40mg calcium chloride, and 0.17mg sodium hydroxide per ml of Recombinant Human Hyaluronidase.*
Principal Display Panel (10 g/100 mL Vial Label)
This is a description of Immune Globulin Infusion 10% (Human), which is a component of HYQVIA. It comes in a single-use vial and is only available with a prescription. The manufacturer is Baxalta US Inc. It also mentions the NDC code for HYQVIA.*
Principal Display Panel (5 mL Vial Label)
This is a description of a single-use vial of Recombinant Human Hyaluronidase which is a component of HYQVIA. The vial has a volume of 5mL and is manufactured by Baxter Healthcare Corporation with a concentration of 160 units per mL. The location of the manufacturer is Deerfield, IL and the lot number is LE-07-40436 with an expiry date of not available.*
Principal Display Panel (10 g/100 mL Kit Carton)
HYQVIA is a dual vial unit for subcutaneous administration that contains One 100mL vial of 0g Immune Globulin Infusion (Human), one 5L vial of 160 units per mL Recombinant Human Hyaluronidase, and one package insert. It is a stabilized solution that can be stored at refrigeration temperature for up to 36 months or at room temperature for three months within the first 24 months from the date of manufacture. HYQVIA is manufactured by Baala US Inc. It is patented and does not contain natural rubber latex. For detailed storage information, see the package insert.*
Principal Display Panel (20 g/200 mL Vial Label)
This text describes a medication called "Immune Globulin Infusion 10% (Human)", which is a component of HYQVIA. It comes in a single-use vial and is only available through prescription (Rx Only). The medication is manufactured by Baala US Inc. and is associated with a license number. The other numbers mentioned are likely identification or tracking numbers.*
Principal Display Panel (10 mL Vial Label)
This is a description of a medical product called "Recombinant Human Hyaluronidase" that comes in a single-use vial and requires a prescription. It is produced by Baxter Healthcare Corporation located in Deerfield, IL, USA. The vial contains 10mL of the product and has a code written as "LE-07-40440". The product has 160 units permL, but no other information is available about its uses, side effects, or recommended dosage.*
Principal Display Panel (20 g/200 mL Kit Carton)
HYQVIA is a single-use, subcutaneous infusion for intravenous immunoglobulin treatment. The immune globulin infusion 10% (human) and recombinant human hyaluronidase combination is contained within a 200mL vial of 20g, along with 10mL vial at 160 units per mL. It is intended for subcutaneous administration only. It should be stored in refrigeration at a temperature of 2°C to 8°C (36°F to 46°F). In the first 24 months from the manufacturing date, it may be stored at room temperature for up to 3 months, but it should not be returned to refrigeration thereafter. This product is not made with natural rubber latex, and each package includes a detailed insert containing all instructions for use, storage information, and manufacturer information.*
Principal Display Panel (30 g/300 mL Vial Label)
The text describes a component called "Immune Globulin Infusion 10% (Human)" which is commonly used in HYQVIA to help fight infections. It is a single-use vial and requires a prescription. It is manufactured by Baalta US Inc. located in Lexington, MA. The license number for the product is 2020. The text contains some errors, as indicated by the jumbled characters at the end.*
Principal Display Panel (15 mL Vial Label)
This is a description of a product called "Recombinant Human Hyaluronidase" that comes in a single-use vial. The product is only available with a prescription (Rx Only), and the vial contains 15 mL of liquid. The manufacturer is Shire Healthcare Corporation, and the product has 160 units per mL. No further information is available.*
Principal Display Panel (30 g/300 mL Kit Carton)
The text appears to be a product description and directions for use of an immune globulin infusion called HYQVIA. It is a 10% human solution with recombinant human hyaluronidase, used for subcutaneous administration only. It comes in a dual vial unit with no preservatives and should not be frozen, but stored in a refrigerated environment. The product is not made with natural rubber latex and is only for Rx use. It is manufactured by Baxalia US Inc. and is a product of Belgium. The product contains stabilized glycine and other ingredients including dibasic sodium phosphate, human albumin, disodium edetate, calcium chloride, and sodium hydroxide. The text also includes patent information and trademarks of the manufacturer.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
